Spravato
KETAMINE NASAL SPRAY – SPRAVATO
Spravato is a nasal spray version of Ketamine that was FDA-approved for the treatment of depression symptoms in 2019.
Spravato has been shown to improve the symptoms of depression which has been resistant to traditional medical treatments. Spravato works in the much same way as IV Ketamine but instead of receiving the medication from an I.V. line, the patient uses a nasal spray. Both medications must be taken at a certified medical facility under the supervision of a healthcare provider.
SPRAVATO VS. I.V. KETAMINE
While both Spravato and I.V. administered Ketamine are effective treatment methods, they do differ in terms of session frequency and affordability. Spravato is covered by most insurance plans while I.V. Ketamine is typically not covered. Please see Insurance Coverage for information regarding insurance coverage, or contact us to learn more.
